HydraScreen: A Generalizable Structure-Based Deep Learning Approach to Drug Discovery
We propose HydraScreen, a deep-learning approach that aims to provide a framework for more robust machine-learning-accelerated drug discovery. HydraScreen utilizes a state-of-the-art 3D convolutional neural network, designed for the effective representation of molecular structures and interactions in protein-ligand binding. We design an end-to-end pipeline for high-throughput screening and lead optimization, targeting applications in structure-based drug design. We assess our approach using established public benchmarks based on the CASF 2016 core set, achieving top-tier results in affinity and pose prediction (Pearson's r = 0.86, RMSE = 1.15, Top-1 = 0.95). Furthermore, we utilize a novel interaction profiling approach to identify potential biases in the model and dataset to boost interpretability and support the unbiased nature of our method. Finally, we showcase HydraScreen's capacity to generalize across unseen proteins and ligands, offering directions for future development of robust machine learning scoring functions. HydraScreen (accessible at https://hydrascreen.ro5.ai) provides a user-friendly GUI and a public API, facilitating easy assessment of individual protein-ligand complexes.
Code (0)
등록된 구현이 없습니다.
Tasks
Drug DesignDrug DiscoveryPose PredictionSimilar Papers 제목 키워드 기반
Learning Subpocket Prototypes for Generalizable Structure-based Drug Design
Generating molecules with high binding affinities to target proteins (a.k.a. structure-based drug design) is a fundamental and challenging task in drug discovery. Recently, deep generative models have achieved remarkable…
3D Molecule GenerationDrug DesignDrug DiscoveryDisentangling Causal Substructures for Interpretable and Generalizable Drug Synergy Prediction
Drug synergy prediction is a critical task in the development of effective combination therapies for complex diseases, including cancer. Although existing methods have shown promising results, they often operate as black…
Drug DiscoveryBSL: A Unified and Generalizable Multitask Learning Platform for Virtual Drug Discovery from Design to Synthesis
Drug discovery is of great social significance in safeguarding human health, prolonging life, and addressing the challenges of major diseases. In recent years, artificial intelligence has demonstrated remarkable advantag…
Drug DiscoveryLaPro-DTA: Latent Dual-View Drug Representations and Salient Protein Feature Extraction for Generalizable Drug--Target Affinity Prediction
Drug--target affinity prediction is pivotal for accelerating drug discovery, yet existing methods suffer from significant performance degradation in realistic cold-start scenarios (unseen drugs/targets/pairs), primarily …
Drug DiscoveryStructure-based drug discovery with deep learning
Artificial intelligence (AI) in the form of deep learning bears promise for drug discovery and chemical biology, $\textit{e.g.}$, to predict protein structure and molecular bioactivity, plan organic synthesis, and design…
Deep LearningDrug Discovery